Add this event to your calendar
At last! Personalized Medicine for Psoriasis brings the International Psoriasis Council (IPC) to the 2026 EADV Congress. This 90-minute symposium examines how personalized care is reshaping psoriasis management. Expert faculty will cover approaches to personalized medicine that move from the clinical picture to the molecular drivers of the disease, therapeutic drug monitoring, and dose optimization, with attention to what works in real-world care, as well as the digital technologies now available for psoriasis. Each of these topics connects current evidence to the decisions dermatologists face in the clinic every day. An extended panel discussion closes the symposium, bringing faculty and panelists together to answer audience questions and consider how these tools translate into daily clinical practice.
Join IPC for a program designed for dermatologists who treat psoriasis and want to know what comes next in care.
Agenda
Welcome and Introduction
Catherine Smith, MD, United Kingdom
Approaches to Personalized Medicine: From the Clinical to the Molecular
Curdin Conrad, MD, Switzerland
Therapeutic Drug Monitoring and Dose Optimization: Clinical and Practical Considerations
Satveer Mahil, PhD, FRCP, United Kingdom
Digital Technologies: What’s Out There for Psoriasis?
Alexander Navarini, MD, PhD, Switzerland
Tamar Nijsten, PhD, Netherlands
Panel Discussion
Faculty and Panelists | Moderated by: Catherine Smith, MD, United Kingdom
Program Chairs
Catherine Smith, MD
Kings College London, and Guys and St Thomas NHS Foundation Trust
London, United Kingdom
IPC Secretary
Program Panelists
